Wanbury Limited — Board Meeting, 26-06-2026: Outcome of Board Meeting
26-06-2026 | 06:52 pm
26-06-2026 | 06:52 pm
Wanbury Pharma's board approved forming a new subsidiary, Wanbury Skin Health, with a 0.041 Cr capital outlay. They also appointed Ernst & Young LLP as Internal Auditor and ABK & Associates as Cost Auditor for FY27. #WanburyPharma #BoardMeeting
No comments yet. Be the first to comment!
